Source: Biomedicine & Pharmacotherapy. Unidades: FMRP, EERP
Subjects: INFECÇÕES POR CORONAVIRUS, COVID-19, MORTALIDADE HOSPITALAR, HIPERTENSÃO, METALOPROTEINASES, UNIDADES DE TERAPIA INTENSIVA, ÍNDICE DE GRAVIDADE DA DOENÇA
ABNT
D'AVILA-MESQUITA, Carolina et al. MMP-2 and MMP-9 levels in plasma are altered and associated with mortality in COVID-19 patients. Biomedicine & Pharmacotherapy, v. 142, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.biopha.2021.112067. Acesso em: 25 ago. 2024.APA
D'Avila-Mesquita, C., Couto, A. E. S. do, Campos, L. C. B., Vasconcelos, T. F., Michelon-Barbosa, J., Corsi, C. A. C., et al. (2021). MMP-2 and MMP-9 levels in plasma are altered and associated with mortality in COVID-19 patients. Biomedicine & Pharmacotherapy, 142. doi:10.1016/j.biopha.2021.112067NLM
D'Avila-Mesquita C, Couto AES do, Campos LCB, Vasconcelos TF, Michelon-Barbosa J, Corsi CAC, Mestriner FLAC, Petroski-Moraes BC, Garbellini-Diab MJ, Couto DMS, Jordani MC, Ferro D, Sbragia L, Joviliano EE, Evora PRB, Santana R de C, Martins-Filho OA, Polonis K, Menegueti MG, Ribeiro MS, Martins MA, Becari C. MMP-2 and MMP-9 levels in plasma are altered and associated with mortality in COVID-19 patients [Internet]. Biomedicine & Pharmacotherapy. 2021 ; 142[citado 2024 ago. 25 ] Available from: https://doi.org/10.1016/j.biopha.2021.112067Vancouver
D'Avila-Mesquita C, Couto AES do, Campos LCB, Vasconcelos TF, Michelon-Barbosa J, Corsi CAC, Mestriner FLAC, Petroski-Moraes BC, Garbellini-Diab MJ, Couto DMS, Jordani MC, Ferro D, Sbragia L, Joviliano EE, Evora PRB, Santana R de C, Martins-Filho OA, Polonis K, Menegueti MG, Ribeiro MS, Martins MA, Becari C. MMP-2 and MMP-9 levels in plasma are altered and associated with mortality in COVID-19 patients [Internet]. Biomedicine & Pharmacotherapy. 2021 ; 142[citado 2024 ago. 25 ] Available from: https://doi.org/10.1016/j.biopha.2021.112067